The NEGR1 gene helps nerve cells grow and connect, especially in the brain, and it may also influence appetite and body weight. This gene plays an important role in how the brain and body communicate about energy balance and development. If the gene does not work properly, these signals may be affected, which can contribute to differences in body weight and, in some people, aspects of brain development or behavior. Common variants linked to the NEGR1 gene usually shift risk only a little rather than causing a clear diagnosis on their own.
What is a gene?
Genes are sections of DNA that give your cells instructions they can use to make molecules or manage processes in the body. Some genes hold the information needed to produce proteins, the parts of cells that do much of the work. Others mainly guide when certain processes happen, where they take place, and how strongly they operate. As a group, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To go into this topic in greater depth, you can find more in the LearnHub.
Overview
NEGR1Gene function
What if the gene works
The NEGR1 gene helps brain cells grow, stick to nearby cells, and form connections. This supports healthy brain development and may influence how nerve networks are organized.
Risk
What if the gene does not work
Changes in the NEGR1 gene can reduce how well nerve cells stick together and communicate at the cell surface. Milder to more severe variants may weaken this role to different degrees, changing how strongly NEGR1 supports nerve cell growth.
Treatment
What does that mean for your treatment
No NEGR1-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the NEGR1 gene. The NEGR1 gene is being studied in obesity biology and in some cancers as a possible biomarker, but this research has not yet changed routine drug choices or clinical management.
Gene function
What if the gene works
In the brain, the NEGR1 gene helps nerve cells connect in an orderly way. It makes a surface protein that guides growing nerve cells and their contact points. This gives a clear picture of what the NEGR1 gene does in the body during normal brain development and everyday nerve cell communication.
The NEGR1 gene makes a protein that sits on the outer surface of certain cells. There, it helps neighboring cells recognize and attach to each other in a controlled way.
This protein supports neurite outgrowth, which means the growth of the branch-like extensions nerve cells use to reach other cells. That guided growth helps build orderly pathways in the developing brain.
NEGR1 also helps organize synapses, the contact points where nerve cells pass signals to one another. By supporting these links, it contributes to steady communication across brain networks.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the NEGR1 gene often affect how much NEGR1 protein a cell makes or whether that protein is processed and displayed on the cell surface. Some NEGR1 gene variants mainly tweak gene activity and have milder cellular effects, while more disruptive variants can shorten the protein, reduce its stability, or prevent interactions between neighboring cells. This range from milder variants to more severe variants can lead to partial loss or near absence of function at the cellular level.
How variants are linked to conditions
Variants in the NEGR1 gene are most consistently linked to body weight, including body mass index and a higher or lower chance of obesity in large population studies. This means the NEGR1 gene and obesity risk are connected, but common variants shift risk rather than determine whether someone will develop obesity. Some studies have explored links with eating behavior and mood, though weight-related associations are the most firmly established.
A variant is not necessarily a diagnosis
Gene variants are a normal part of human biology and are widespread in the general population. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
Changes in the NEGR1 gene are linked with body weight tendency rather than a certain diagnosis, and their effect is usually small. Risk can shift with many other genes, eating patterns, sleep, stress, physical activity, and some medicines. A NEGR1 result does not mean someone will definitely develop obesity or stay at a certain weight.
Inheritance of NEGR1 variants
There is not yet a broadly confirmed Mendelian inheritance pattern for NEGR1-related health effects, because most reported links involve risk traits rather than a single condition passed down in a clear dominant or recessive way. Inheritance of NEGR1 gene variants is therefore usually discussed as part of complex, shared family risk, where many genes and life factors act together. The NEGR1 gene is located on chromosome 1, which is an autosome, so you inherit one copy from each parent. This means NEGR1 variants can be passed to children of any sex through either side of the family.
What does my NEGR1 result mean for my family?
There is not yet a broadly confirmed inherited pattern tied to a specific NEGR1-related condition in the way there is for some single-gene conditions. A NEGR1 result is usually understood as one small piece of overall health risk, not something that clearly predicts the same result or outcome in relatives.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the NEGR1 gene, a lab can analyze DNA from a saliva or blood sample. How genetic testing for NEGR1 variants works is straightforward: the lab reads this part of your DNA and looks for specific changes. Results usually add risk information rather than giving a diagnosis on their own.
When should I consider getting a genetic test?
There is not yet a broadly established NEGR1-specific reason for genetic testing in routine care. Testing decisions are usually based on your personal health and family history, together with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it explains varies with the condition and the kind of variant identified. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. In some conditions, particularly those shaped by many genes, genetic information provides added context rather than certainty and is most useful when considered with other parts of care. In other situations, a genetic result can give a clear answer. For medication response, genetic results may also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same medication may work well for one person, work less well for another, or cause more side effects in someone else. These differences are common and are one part of the bigger picture, along with age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics is the study of how genetic differences affect the way a person responds to medication. It examines gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support more informed, more personalized treatment decisions. More about this topic is available in the LearnHub.
Drugs influenced by the NEGR1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted. If you have medication side effects, new symptoms, or concerns about your treatment, talk with your doctor.
History
NEGR1 entered medical genetics through large genome-wide studies in the late 2000s, when researchers looking across the whole DNA sequence found common variants near the NEGR1 gene linked to body weight. In recent decades, awareness of this gene’s role has grown as repeated studies connected the same region to obesity risk in different populations. From these first observations, research expanded steadily, and NEGR1 became part of the broader story of how many genes can shape body size and eating-related traits. Later work also explored links with brain development and behavior, which widened scientific interest. The way this gene was viewed has shifted over time, from a statistical signal in large studies to a gene examined more directly in biology research.